GLP-1 drugs such as semaglutide — the active ingredient in Ozempic and Wegovy — may slow biological aging, a new study suggests. Researchers at the University of California at San…
Author: Sophie Hargreaves
A new blood test can detect thousands of foetal genetic conditions, offering a safer alternative to invasive procedures such as amniocentesis and chorionic villus sampling (CVS) for pregnancies where a…
Prostate cancer is the most common cancer diagnosed in men across the United Kingdom, with official figures showing that roughly one in eight men will receive a diagnosis in their…
The U.S. Food and Drug Administration (FDA) has issued a fresh warning to consumers about the risk of kidney problems linked to the over-the-counter weight loss pill Alli, prompting changes…
Two unfolding outbreaks continue to command global attention. As a hantavirus outbreak tied to a cruise ship appears to be petering out, Ebola cases continue to mount in Africa. Alongside…
Britain first in Europe to approve oral Wegovy tablet Britain has become the first country in Europe to authorise an oral tablet form of the weight-loss drug semaglutide, marketed as…
Lithium, a drug long used to stabilise the moods of people with bipolar disorder, may prove to be a crucial weapon against Alzheimer’s disease, with researchers now suggesting that a…
When the 2026 FIFA World Cup kicks off on June 11, measles will pose a far greater threat to the millions of fans packing stadiums, airports and bars than the…
New headphones being developed at the University of Washington’s Mobile Intelligence Lab use machine learning to selectively eliminate irritating noises while leaving desired sounds untouched, offering wearers a previously impossible…
Men are turning to fat-dissolving injections on their pubic area in an attempt to enlarge the appearance of their penis, a practice promoted by influencers within the “looksmaxxing” community but…